These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 7785749)

  • 21. Medical therapy for ocular allergy.
    Trocme SD; Raizman MB; Bartley GB
    Mayo Clin Proc; 1992 Jun; 67(6):557-65. PubMed ID: 1359206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic science and pathophysiology of ocular allergy.
    Calder VL; Lackie PM
    Curr Allergy Asthma Rep; 2004 Jul; 4(4):326-31. PubMed ID: 15175149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergic eye disease--a clinical challenge.
    Buckley RJ
    Clin Exp Allergy; 1998 Dec; 28 Suppl 6():39-43. PubMed ID: 9988434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy.
    Baiula M; Bedini A; Baldi J; Cavet ME; Govoni P; Spampinato S
    Drug Des Devel Ther; 2014; 8():745-57. PubMed ID: 24959069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lirentelimab for severe and chronic forms of allergic conjunctivitis.
    Anesi SD; Tauber J; Nguyen QD; Chang P; Berdy GJ; Lin CC; Chu DS; Levine HT; Fernandez AD; Roy N; Asbell PA; Kantor AM; Chang AT; Singh B; Youngblood BA; Jeng BH; Jhanji V; Rasmussen HS; Foster CS
    J Allergy Clin Immunol; 2022 Sep; 150(3):631-639. PubMed ID: 35390403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Allergic Conjunctivitis Induced by House Dust Mite Extract From Dermatophagoides pteronyssinus.
    Lee YJ; Han SJ; Lee H; Kim JS; Seo KY
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1773-81. PubMed ID: 27074380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune mechanisms in allergic eye diseases: what is new?
    Offiah I; Calder VL
    Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):477-81. PubMed ID: 19620858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases.
    Shoji J
    Allergol Int; 2020 Oct; 69(4):496-504. PubMed ID: 32563624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis.
    Trocme SD; Kephart GM; Allansmith MR; Bourne WM; Gleich GJ
    Am J Ophthalmol; 1989 Jul; 108(1):57-63. PubMed ID: 2750834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ocular allergies].
    Messmer EM
    Ophthalmologe; 2005 May; 102(5):527-43; quiz 544. PubMed ID: 15806370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Damage-Associated Molecular Patterns (DAMPs/Alarmins) in Severe Ocular Allergic Diseases.
    Fukuda K; Ishida W; Kishimoto T; Nakajima I; Miura Y; Sumi T; Yamashiro K
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The murine CCR3 receptor regulates both eosinophilia and hyperresponsiveness in IgE-mediated allergic conjunctivitis.
    Fukuda K; Kuo CH; Morohoshi K; Liu FT; Ono SJ
    Br J Ophthalmol; 2012 Aug; 96(8):1132-6. PubMed ID: 22694967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis.
    Kumagai N; Fukuda K; Fujitsu Y; Yamamoto K; Nishida T
    Prog Retin Eye Res; 2006 Mar; 25(2):165-87. PubMed ID: 16427347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Different clinical forms of conjunctival allergy].
    Creuzot-Garcher C
    J Fr Ophtalmol; 2007 Mar; 30(3):288-91. PubMed ID: 17417156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosing and managing allergic conjunctivitis in childhood: The allergist's perspective.
    Fauquert JL
    Pediatr Allergy Immunol; 2019 Jun; 30(4):405-414. PubMed ID: 30742722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Knowledge in Allergic Conjunctivitis.
    Villegas BV; Benitez-Del-Castillo JM
    Turk J Ophthalmol; 2021 Feb; 51(1):45-54. PubMed ID: 33631915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular allergic inflammation: interaction between the cornea and conjunctiva.
    Fukuda K; Nishida T
    Cornea; 2010 Nov; 29 Suppl 1():S62-7. PubMed ID: 20935545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The central role of conjunctival mast cells in the pathogenesis of ocular allergy.
    Leonardi A
    Curr Allergy Asthma Rep; 2002 Jul; 2(4):325-31. PubMed ID: 12044269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular allergy: diagnosis and treatment.
    Butrus S; Portela R
    Ophthalmol Clin North Am; 2005 Dec; 18(4):485-92, v. PubMed ID: 16314214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.